Serum metabolomics identifies novel prognostic biomarkers in amanita poisoning

Serum metabolomics has identified metabolic biomarkers capable of predicting mortality in <i>Amanita</i> poisoning, with significant correlation to liver and coagulation injury. These biomarkers may facilitate early risk stratification and guide targeted therapeutic interventions. Limitations include small sample size and single-center retrospective design, which may restrict result generalizability.